News 16.08.2013

We kindly inform that the process of scientific review of initial applications within the program STRATEGMED – NCBiR is completed. 28 initial applications were qualified to further proceedings. Kardio-Med Silesia Ltd as one of the consortium partners is qualified for the second stage in two projects:
Project: “The use of medical data tele transmission in order to improve the quality of patient’s life with heart failure and the reduction of the cost of their treatment – Project MONITEL-HF”.
Project: “Strategy development of The Transregional Scientific Network focused on heart stem cell research and their use in the treatment of patients with chronic heart failure – PEGASUS”.

Please also note that recruitment of applications will start no earlier than 5 November, 2013 (open only to applicants whose applications have been pre-qualified for the second stage).

The final verdict of the program STRATEGMED – NCBiR should take place by the end of the first quarter of 2014.